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T 
he stunned myocardium has recently become the 
focus of considerable interest because of its po- 
tential role in negating the benefits of reperfu- 
sion. A critical but still unresolved issue relates to the 
mechanism responsible for this contractile abnormality. 
In recent years an increasing number of studies have 
provided indirect evidence that postischemic myocardial 
dysfunction may be mediated in part by the generation of 
reactive oxygen species, such as superoxide radical, hy- 
drogen peroxide and hydroxyl radical. These oxygen-free 
radicals could arise from various sources, such as hy- 
poxanthine conversion by xanthine oxidase, catechol- 
amine degradation and mitochondrial electron transport. 
Direct evidence of injury by free radicals has yet to be 
shown in the human heart, but many studies of other 
mammals have linked reactive oxygen metabolites with 
myocardial injury. l-5 During myocardial ischemia, xan- 
thine dehydrogenase (which appears to be located in the 
endothelial cells)‘j is converted to xanthine oxidase, an 
enzyme that produces supcroxide radical, hydrogen per- 
oxide and uric acid from hypoxanthine or xanthine and 
molecular oxygen.7 At the same time, ischemia is associ- 
ated with rapid catabolism of adenosine triphosphate.7 
This degradation of adenosine triphosphate causes an 
efflux of breakdown products that are able to pass 
through the cell membrane, resulting in an accumulation 
of hypoxanthine, 1 of 2 substrates for xanthine oxidase. 
The other substrate (molecular oxygen) is provided by 
reperfusion, which results in a burst of free-radical gener- 
ation. These free radicals initiate chain reactions caus- 
ing peroxidative breakdown of polyunsaturated fatty 
acids in the membrane bilayer.9-12 The interaction 
among oxygen-free radicals with polyunsaturated fatty 
acids has been described as lipid pet-oxidation and can be 
measured by formation of malondialdehyde. Until re- 
cently, the assessment of alterations in myocardial me- 
tabolism in humans early after short and repetitive occlu- 
sions of a major coronary artery has not been feasible. 
However, percutaneous transluminal coronary angio- 
plasty provides a unique opportunity to study the time 
course of these metabolic changes during transient inter- 
ruption of coronary flow by the balloon-occlusion se- 
quence in patients with 1 -vessel disease and without angi- 
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ographically demonstrable collateral circulation.t3-I6 In 
this report we studied the production of hypoxanthine, 
urate and malondialdehyde during percutaneous translu- 
minal coronary angioplasty. 
All patients met the following criteria: a brief his- 
tory of anginapectoris (<I year), an isolated obstruc- 
tive lesion in the left anterior descending coronary 
artery, and an accessible stenosis of <I cm in length. 
All patients were candidates for coronary artery by- 
pass graft surgery because of disabling angina, but 
were selected for angioplasty rather than surgery be- 
cause of their anatomy. Ten patients (8 men and 2 
women, aged 37 to 72 years) were studied. Of these, 4 
were in New York Heart Association class II, 5 in 
class III and 1 in class IV. In all, the ejection fraction 
was >SO% and none of them had wall motion abnor- 
malities on their left ventriculograms at rest. Four 
consecutive transluminal dilatations of 90 seconds 
each with dejlation intervals of 3 minutes were per- 
formed. All patients gave informed consent and there 
were no complications directly related to the research 
procedure. 
A Pepine catheter was inserted in the coronary 
sinus with the end-hole positioned at the origin of the 
great cardiac vein for blood sampling. Arteriovenous 
differences of blood hypoxanthine. urate and malon- 
dialdehyde were determined at baseline immediately 
after each balloon deflation and, ftnally, 5 and 15 
minutes after the percutaneous transluminal coronary 
angioplasty procedure. 
HYPOXANTHINE AND URATE: Great cardiac vein and 
femoral arterial blood samples were collected in hep- 
arinized tubes with equal volumes of cold 154 mA4 
sodium chloride, containing 20 t&l dipyridamole 
(Boehringer, Ingelheim, Federal Republic of Germa- 
ny), and 10 t&l erythro-9-(2-hydroxy-3-nonyl) ade- 
nine hydrochloride ( Wellcome, London, Great Brit- 
ain). These drugs were used to inhibit adenosine up- 
take and breakdown. Mixtures were centrifuged in the 
cold. The supernatant fluids were stored at -80°C. 
On the day of analysis, these were thawed and mixed 
with cold 8% perchloric acid. Hypoxanthine and urate 
were assayed by high-performance liquid chromatog- 
raphy using the method of Huizer et a1.‘7 
MALONDIALDEHYDE: After separation of blood cells 
by centrifugation at 0 to 4” C, the plasma was frozen 
in liquid nitrogen and stored at -80°C. The malon- 
392 THE AMERICAN JOURNAL OF CARDIOLOGY VOLUME 68 AUGUST 1. 1991 
7 - 
TABLE I Vein-Arterial Hypoxanthine Difference in the 10 
Patients 
1 2 3 4 5 6 
BL -0.224 0.473 -0.267 -0.446 -0.160 -0.320 
Post1 0.169 0.648 0.805 6.392 0.649 1.990 
Post2 2.606 0.522 2.367 28.410 0.747 1.117 
Post3 1.941 0.891 2.429 23.934 3.039 1.385 
Post4 0.815 3.070 4.163 2.080 0.467 1.510 
R5 0.542 -0.069 5.940 0.938 0.562 -0.042 
R15 0.336 0.205 6.114 0.415 -0.521 -0.364 
7 8 9 10 Mean -+ SEM 
BL 0.410 0.447 0.847 0.587 0.14 2 0.15 
post1 3.250 0.467 5.968 0.273 2.06 2 0.75 
Post2 3.160 1.740 2.939 30.910 7.45 k 3.72 
Post3 1.500 4.010 2.160 27.060 6.83 + 3.13 
Post4 -0.978 0.840 1.160 7.441 2.06 2 0.75 
R5 -0.010 0.800 -0.660 5.900 1.39 + 0.76 
R15 -0.460 -0.300 -0.440 -0.460 0.45 2 0.63 
Individual hypoxanthine vein-arterial difference in the 10 patients during baseline 
(EL), immediately after the 4 percutaneous transluminal coronary angioplasty infla- 
tions and, finally, 5 and 15 minutes after the percutaneous transluminal coronary 
angioplasty procedure (R5, R15). 
Post = after: SEM = standard error at the mean. 
TABLE II Vein-Arterial Urate Differenceinthe 10 Patients 
1 2 3 4 5 6 
BL 10 7 6 21 -7 4 
Postinfl 1 -15 2 6 5 11 5 
Postinfl2 -1 4 -2 2 5 -2 
Postinf13 -5 6 2 6 19 10 
Postinfl4 5 11 29 6 -28 6 
R5 -2 40 43 17 -7 2 
R15 -4 5 17 4 -14 -3 
7 8 9 10 Mean 2 SEM 
BL -6 -9 6.4 -9 2.34 _' 3.12 
Postinfll -2 -3 2 3.7 1.47 -+ 2.22 
Postinf12 3 3.6 5 -2 1.56 2 0.95 
Postinf13 8 9 -11 13.8 5.78 r 2.76 
Postinfl 4 18 19.8 -17 30 7.98 r 5.87 
R5 15 29 -14 52 17.50 +- 7.23 
R15 3 10 -13 8.2 1.32 2 3.12 
See legend in Table I. 
Postinfl = after inflation; other abbreviations as in Table I. 
TABLE III Vein-Arterial Malondialdehyde Differenceinthe 10 
Patients 
dialdehyde content of the plasma samples was mea- 
HYPOXANTHINE PRODUCTION: We studied hypoxan- 
thine production by measuring vein arterial hypoxan- 
thine concentration. Baseline value was +O. I4 f 0.15 
PM. After the first dilatation, vein-arterial hypo- 
xanthine concentration significantly increased to 
+2.06 f 0.75 PM (p <O.Ol us baseline), after the sec- 
ond to +7.45 f 3.7, after the third to +6.83 f 3.13, 
and after the fourth to +2.06 f 0.75 PM. Five min- 
sured in the presence of 100 PM ethylene diaminete- 
utes after thefourth occlusion the vein-arterial differ- 
ence remained significantly increased (+I .39 f 0.76; 
p CO.05 us baseline), whereas after 15 minutes recov- 
ery vein-arterial difference returned to baseline values 
(+0.45 f 0.63 PM; p = not significant [NSj us base- 
line). Detailed hypoxanthine production3gures of the 
10 patients are listed in Table I. 
traacetic acid as described by Jackson et a1.18 The 
extinction coef$cient of the thiobarbituric acid prod- 
uct was taken as 1.56 X 105 M-l cm-l for all calcula- 
tions of the malondialdehyde content. 
Values are reported as mean f standard error of 
the mean. Comparison between results before and af- 
ter percutaneous transluminal coronary angioplasty 
and occlusion conditions were evaluated using analy- 
sis of variance for repeated measurements. When 
overall significance was found, multiple comparisons 
were considered signiYcantly different at p cO.O.5, 
The relation between uric acid and malondialdehyde 
arteriovenous difference was evaluated by linear re- 
gression analysis. 
was +1.47 f 2.22 PM (NS us baseline), after the sec- 
ond +1.56 f 0.95 PM (NS vs baseline), after the third 
l 
+5.78 f 2.76 g*M (p <O.Ol us baseline), and after the 
2 
fourth +7.98 f 5.87 (p <O.Ol us baseline). After 5- 
3 
minute reoxygenation, vein-arterial urate difference 
4 
further increased to +17.50 f 7.23 PM (p <O.OOl), 
5 
whereas 1.5 minutes after the last inflation, vein-arte- 
6 
rial urate difference normalized (+I .32 f 3.12 PM, 
NS). Detailed urate production figures of the IO pa- 
BL 
tients are listed in Table II. 
-0.32 -0.39 0.96 1.88 -1.67 1.30 
Post1 0.30 1.07 0.83 -0.55 -1.04 1.52 
Post2 1.27 -0.64 -0.1 0.79 1.07 -0.43 
Post3 -1.29 -0.65 3.47 2.73 -0.92 1.06 
Post4 -1.40 -1.00 2.67 2.38 1.5 -1.42 
R5 -1.73 1.35 3.5 3.22 -1.48 -2.36 
R15 -1.07 0.23 -0.96 -0.23 -0.37 1.39 
7 8 9 10 Mean k SEM 
Fkst 1 0.10 -1.88 -0.47 -1.71 -0.22 2 0.41 
0.29 1.19 -1.94 1.73 0.34 2 0.37 
Post2 0.66 1.37 0.31 0.23 0.45 t 0.22 
Post3 0.93 3.60 2.44 -1.44 0.99 r 0.63 
Post4 1.01 1.68 2.22 3.85 1.15 k 0.58 R5 
0.59 3.73 5.30 5.28 1.74 +- 0.91 
R15 -0.63 1.06 -0.96 0.86 -0.07 2 0.29 
See legend in Table I. 
MALONDIALDEHYDE PRODUCTION: Before percutane- 
ous transluminal coronary angioplasty, vein-arterial 
malondialdehyde was -0.22 f 0.41 PM, after the 
first dilatation it increased to +0.34 f 0.37 PM 
(NS us baseline), after the second occlusion to 
+0.45 f 0.22 PM 0, <0.05 us baseline), after the 
third to +0.99 f 0.63 PM (p CO.01 vs baseline), and 
after thefourth to +1.15 f 0.58 pM(p KO.01 us base- 
URATE PRODUCTION: We observed a baseline urate 
vein-arterial difference of -I-2.34 f 3.12 PM. After 
the first dilatation, urate vein-arterial difference 
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line). After 5-minute reperfusion, uein-arterial ma- 
londialdehyde further increased to 1.74 f 0.91 PM 
(p CO.01 us baseline). Finally, after 15 minutes it re- 
turned to baseline levels (-0.07 f 0.29 PM, NS). De- 
tailed malondialdehyde production figures of the 10 
patients are shown in Table III. 
The present data show that short repetitive coronary 
total occlusions of the left anterior descending artery 
during percutaneous transluminal coronary angioplasty 
procedure lead to a significant increase of great cardiac 
vein-arterial concentrations of hypoxanthine, uric acid 
and malondialdehyde (Figure 1). For malondialdehyde, 
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flGURE 1. Hypoxanthine (a), uric acid (b) and mabndialde- 
hyde (c) vein-arterial (V-A) 8lmmmes during baceline (BL), 
Ime aRer the 4 percutaneous tramihmninal coronary 
angiaplasty inftatbs and, finally, 5 and 15 miwtes at&r the 
vein-arterial difference showed a progressive increase 
that peaked 5 minutes after the last inflation. The regres- 
sion analysis between uric acid and malondialdehyde 
vein-arterial difference was not significant (r = 0.34, 
NS), which also suggests that other oxygen-free radical 
sources may play a role. On average, uric acid vein- 
arterial difference parallels that of malondialdehyde, in 
contrast to hypoxanthine vein-arterial difference, which 
peaked around the second and third inflations. Pro- 
duction of malondialdehyde reflects lipid peroxidation, 
which suggests production of oxygen-free radicals, so the 
production of malondialdehyde in this model likely re- 
sults from the generation of oxygen-free radicals.g-12 
However, malondialdehyde is only one of many products 
of lipid peroxidation. The reaction between thiobarbi- 
turic acid and malondialdehyde produces a pink color 
that can be measured by spectrophotometry. This assay 
has been used to study circulating lipoperoxides in many 
diseases.1g-21 The assay used in this study usually gives 
higher malondialdehyde concentrations than are actually 
present because not only is malondialdehyde measured 
but also other aldehydes. Furthermore, it measures both 
preexisting malondialdehyde and all other substances 
that give rise to malondialdehyde during the assay (in 
vitro and in vivo). In addition, several chemical species 
other than malondialdehyde can react with thiobarbi- 
turic acid to produce a pink to red color.22 This relative 
lack of specificity of the thiobarbituric assay has been 
criticized, but malondialdhyde appears to be produced in 
a relatively constant proportion to the rate of lipid peroxi- 
dation23; thus, when all samples from 1 patient are as- 
sayed simultaneously, the results should reflect the de- 
gree of peroxidation. There are several potential sources 
of oxygen-free radicals during human myocardial ische- 
mia/reperfusion. 1,24 First, ischemia itself may produce 
cytotoxic free radicals as a result of reactions involving 
mitochondrial electron transfer25 after catecholamine 
degradation by monoamine oxidases, autooxidation or, 
what is more likely at physiological pH, metal-catalyzed 
oxidation.tt2’j Second, the univalent reduction of oxygen 
by activated neutrophils, 1,27 though an important source 
of radicals, is probably not relevant in transient ischemia 
because it is likely that the chemotactic factors required 
to promote neutrophil migration into ischemic tissue re- 
quire several hours for full expression.28 Third, the action 
of endothelial xanthine oxidase on purine metabolites 
accumulated during ischemia is another possible system 
for generating oxygen-free radicals. 19~29,30 Published 
data on xanthine oxidase in human myocardium are 
controversial,30 perhaps owing to the fact that the en- 
zyme can inactivate itself. 31 We found urate production 
after angioplasty, l5 but not by isolated perfused human 
heart3u The parallel production of urate and malondial- 
dehyde after repetitive coronary occlusions in the angio- 
plastic procedure suggests the possible importance of this 
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pathway in the production of oxygen-free radicals in the 
human ischemic heart. These radicals may play a role in 
the persistence of regional left ventricle dysfunction after 
reperfusion. 
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Waking Up Exhausted as Risk Indicator of Myocardial Infarction 
Ad Appels, PhD, and Erik Schouten 
D uring the last decade several studies have indi- cated that sleep problems might belong to the risk indicators for coronary artery disease 
(CAD). For example, a 6-year follow-up study of 
>lO,OOO subjects revealed a risk of 2.04 for CAD in 
“poor” versus “good” sleepers.’ Little is known about the 
typs of sleep complaints that are associated with future 
CAD. One may speculate that trouble falling asleep is 
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associated with CAD, because this is indicative of pro- 
longed tension. Trouble staying asleep may be predictive 
for the same reason, or because it is indicative of a heart 
failure or nocturnal angina. Waking up tired may reflect 
an impaired sleep or an adverse effect of medication, 
angina pectoris or aging, and lose its predictive power 
when adjusted for these factors. 
Waking up tired may also indicate depression. Recent 
meta-analyses of the vast literature of personality factors 
and CAD have shown that, of all personality attributes, 
depression is the one most strongly associated with dis- 
ease outcome.2 Because early-morning tiredness is a ma- 
jor characteristic of depression it is predicted that prob- 
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